Invention Publication
![2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS](/docs/US/2024-05-02/US20240140959A1/abs.jpg.600x600.jpg)
- Patent Title: 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
-
Application No.: US18497296Application Date: 2023-10-30
-
Publication No.: US20240140959A1Publication Date: 2024-05-02
- Inventor: Amy CALHOUN , Xin CHEN , Kevin Matthew GARDINIER , Edward Charles HALL , Keith JENDZA , Nancy LABBE-GIGUERE , James Anthony NEEF , Daniel Steven PALACIOS , Ming QIAN , Michael David SHULTZ , Christopher G. THOMSON , Kate Yaping WANG , Fan YANG
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- The original application number of the division: US17065367 2020.10.07
- Main IPC: C07D491/107
- IPC: C07D491/107 ; A61K45/06 ; A61P25/18
![2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS](/abs-image/US/2024/05/02/US20240140959A1/abs.jpg.150x150.jpg)
Abstract:
Provided herein are compounds according to Formula (I)
or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
Information query
